As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's Hospital, published in Cell, finds that the brain's resident immune cells, ...
Memorial Sloan Kettering scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...
Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...
A large-scale genomic study published February 19 in Science has produced the first comprehensive map of the feline ...
The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results